Dimitris Voliotis - 19 Oct 2026 Form 4 Insider Report for Radiopharm Theranostics Ltd (RADX)

Reporting relationship: Chief Medical Officer
Issuer ticker: RADX
Reported as of: 19 Oct 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 27 Oct 2026, 19:08:10 UTC
Prior SEC filing: 06 May 2026
Source filing: View source filing
Reporting owner signature: /s/ Dimitris Voliotis

Filing notes and source

Key filing fact

Dimitris Voliotis filed Form 4 for Radiopharm Theranostics Ltd (RADX) on 27 Oct 2026.

Key facts

This page summarizes Dimitris Voliotis's Form 4 filing for Radiopharm Theranostics Ltd (RADX).
2 reported transactions and 2 derivative rows are listed below.
Accepted by SEC: 27 Oct 2026, 19:08.

Change

Previous filing in this sequence was filed on 06 May 2026.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001807910 Primary reporting owner

Voliotis Dimitris

Relationship: Chief Medical Officer
Address: SUITE 1, LEVEL 3, 62 LYGON STREET, CARLTON SOUTH, VICTORIA
Signature: /s/ Dimitris Voliotis
Signature date: 27 Oct 2026

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

RADX transaction Derivative

Option (Right to buy)

Award

Transaction value
Shares: +10,295,667
Change %
Price: $0.000000^*
Shares after: 10,295,667
Date: 19 Oct 2026
Ownership: Direct
Underlying class: Ordinary Shares
Underlying amount: 10,295,667
Exercise price: $0.0210

RADX transaction Derivative

Option (Right to buy)

Award

Transaction value
Shares: +10,295,666
Change %
Price: $0.000000^*
Shares after: 10,295,666
Date: 19 Oct 2026
Ownership: Direct
Underlying class: Ordinary Shares
Underlying amount: 10,295,666
Exercise price: $0.0210

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

SEC remarks

All exercise prices are in Australian dollars. There are no non-derivative securities beneficially owned.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. to update or revoke optional consent for future visits. For more information, see our Privacy Policy .